AM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally restricted manner-Reference-Cited by-同舟云学术

AM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally restricted manner

Published:2015-02-27 Issue:9 Volume:172 Page:2406-2418
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Keenan C M¹²,Storr M A²³⁴,Thakur G A⁵,Wood J T⁵,Wager-Miller J⁶,Straiker A⁶,Eno M R⁵,Nikas S P⁵,Bashashati M¹²,Hu H¹⁷,Mackie K⁶,Makriyannis A⁵,Sharkey K A¹²

Affiliation:

1. Hotchkiss Brain Institute; Department of Physiology and Pharmacology; Cumming School of Medicine; University of Calgary; Alberta Canada

2. Snyder Institute for Chronic Diseases; Cumming School of Medicine; University of Calgary; Alberta Canada

3. Division of Gastroenterology; Department of Medicine; Cumming School of Medicine; University of Calgary; Alberta Canada

4. Department of Medicine; Ludwig-Maximilians University; Munich Germany

5. Center for Drug Discovery; Northeastern University; Boston MA USA

6. Department of Psychological and Brain Sciences; Gill Center for Biomolecular Science; Indiana University; Bloomington IN USA

7. Division of Gastroenterology; Department of Internal Medicine; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Taiwan

Funder

National Institutes of Health

Canadian Institutes of Health Research

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bph.13069/fullpdf

Reference66 articles.

1. The gastrointestinal pharmacology of cannabinoids: focus on motility;Abalo;Pharmacology,2012

2. Low brain penetrant CB1 receptor agonists for the treatment of neuropathic pain;Adam;Bioorg Med Chem Lett,2012